CEAPRO
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and "active ingredients" from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals. The Company has a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.
CEAPRO
Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics
Founded:
1997-01-01
Address:
Edmonton, Alberta, Canada
Country:
Canada
Website Url:
http://www.ceapro.com
Total Employee:
11+
Status:
Active
Contact:
(780) 421-4555
Email Addresses:
[email protected]
Total Funding:
1.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Amazon
Similar Organizations
CorneaCare
Personalized dry eye treatment delivered and monitored.
Preciva
Preciva is developing electronic screening tools to give every woman an equal chance to live free of cervical cancer.
UPMC
UPMC is one of the leading nonprofit health systems in the United States. A $10 billion integrated global health enterprise headquartered
VitaCare
VitaCare is a healthcare services platform that helps patients navigate access to brand medications.
Current Employees Featured
Founder
Stock Details
Investors List
National Research Council of Canada Industrial Research Assistance Program
National Research Council of Canada Industrial Research Assistance Program investment in Grant - Ceapro
National Research Council Canada
National Research Council Canada investment in Grant - Ceapro
Natural Sciences and Engineering Research Council of Canada (NSERC)
Natural Sciences and Engineering Research Council of Canada (NSERC) investment in Grant - Ceapro
Canadian Institutes of Health Research
Canadian Institutes of Health Research investment in Grant - Ceapro
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer |
Official Site Inspections
http://www.ceapro.com Semrush global rank: 8.69 M Semrush visits lastest month: 266
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Ceapro"
Management Team :: Ceapro Inc.
Prior to joining Ceapro, he was President and CEO of Aeterna Zentaris, a Nasdaq-listed biopharmaceutical company. During the past 35 years, Mr. Gagnon has worked at several …See details»
Ceapro - Crunchbase Company Profile & Funding
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and …See details»
Overview :: Ceapro Inc.
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights. Apr 29, 2024. Read Press ReleaseSee details»
Ceapro - LinkedIn
Ceapro Inc. is a Canadian biotechnology company involved in the development and commercialization of “active ingredients” derived from oats and other renewable plant …See details»
Ceapro Inc. - AnnualReports.com
Ceapro Inc. is a Canadian biotechnology company involved in the development and commercialization of “active ingredients” derived from oats and other renewable plant …See details»
Ceapro - Contacts, Employees, Board Members, Advisors
Ceapro is into developing functionally active ingredients derived from oats and renewable plant resources for healthcare and cosmetic needs.See details»
Ceapro Inc. | Independent Equity Research | Crystal Research …
Nov 13, 2016 Ceapro Inc. 7824 – 51 Avenue Edmonton, AB T6E 6W2, Canada Phone: (780) 421-4555 Fax: (780) 421-1320 www.ceapro.comSee details»
Ceapro Provides Business Update on Progress of Ongoing …
Feb 23, 2024 Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of …See details»
Ceapro Provides Business Update on Progress of Ongoing …
Feb 23, 2024 Samples of powder formulation have been successfully prepared and shipped to Symrise AG, Ceapro’s long-term partner, for liquid reformulation and assessment for the …See details»
Ceapro Inc. Announces Dosing of First Patients in Phase 1-2a …
Dec 13, 2023 The Montreal Health Innovations Coordinating Center (MHICC) is a leading full-service academic clinical research organization and an integral part of the Montreal Heart …See details»
Ceapro Inc. Reports 2023 Financial Results and Operational
Apr 29, 2024 --Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today …See details»
Ceapro Inc. Reports 2023 Financial Results and Operational …
Apr 29, 2024 – Sales impacted (decreased by 49% from $18.8M in 2022 to $9.6M in 2023) due to re-organization associated with the spin-off of the consumer division of one major customer …See details»
Ceapro Inc. Reports 2023 Second Quarter and Six-Month Financial …
EDMONTON, Alberta, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company …See details»
Ceapro Inc. Reports Fourth Quarter and Full Year 2019 Results and ...
EDMONTON, Alberta, April 16, 2020 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company …See details»
Ceapro Provides Business Update on Progress of Ongoing …
Feb 23, 2024 Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of …See details»
Ceapro Inc. Initiates Phase 1-2a Study Assessing Its Flagship …
Nov 27, 2023 Ceapro Inc. Study being led by Dr. Jean-Claude Tardif at the Montreal Heart Institute. Screening of healthy subjects is now underway . Phase 1-2a study to provide …See details»
Ceapro Announces Next Phase of Research Collaboration with
Jul 18, 2023 Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of …See details»
Ceapro Inc. Reports Fourth Quarter and Full Year 2020 Financial …
EDMONTON, Alberta, April 22, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO, OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company …See details»
Ceapro Inc. Reports Record 2022 Second Quarter and Six-Month …
EDMONTON, Alberta, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company …See details»
Ceapro Inc. Reports 2021 Second Quarter and Six-Month Financial …
EDMONTON, Alberta, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company …See details»